TY - JOUR
T1 - Polymicrobial aetiology of travellers' diarrhoea
AU - Taylor, David N.
AU - Blaser, Martin J.
AU - Blacklow, Neil
AU - Echeverria, Peter
AU - Pitarangsi, Chittima
AU - Cross, John
AU - Weniger, Bruce G.
PY - 1985
Y1 - 1985
N2 - Of 35 US Peace Corps volunteers in Thailand, 20 (57%) had a total of 30 episodes of diarrhoea during their first 6 weeks in the country. Enteric pathogens were associated with 90% of the episodes. A single pathogen was identified in 17 (57%) episodes, 2-4 pathogens were identified in 10 (33%) episodes, and there were 15 symptomless infections. Enterotoxigenic Escherichia coli (ETEC) was identified in 37% of these episodes, and various salmonella serotypes were isolated in 33%. Infectious with 9 other enteric pathogens were also identified: Campylobacter jejuni (17%), Plesiomonas shigelloides (13%), Aeromonas hydrophila (10%), Blastocystis hominis (7%), Norwalk virus (7%), Vibrio parahaemolyticus (3%), non-O1 Vibrio cholerae (3%), Vibrio fluvialis (3%), and rotavirus (3%). In total, 56 enteric infections were documented in 35 volunteers.
AB - Of 35 US Peace Corps volunteers in Thailand, 20 (57%) had a total of 30 episodes of diarrhoea during their first 6 weeks in the country. Enteric pathogens were associated with 90% of the episodes. A single pathogen was identified in 17 (57%) episodes, 2-4 pathogens were identified in 10 (33%) episodes, and there were 15 symptomless infections. Enterotoxigenic Escherichia coli (ETEC) was identified in 37% of these episodes, and various salmonella serotypes were isolated in 33%. Infectious with 9 other enteric pathogens were also identified: Campylobacter jejuni (17%), Plesiomonas shigelloides (13%), Aeromonas hydrophila (10%), Blastocystis hominis (7%), Norwalk virus (7%), Vibrio parahaemolyticus (3%), non-O1 Vibrio cholerae (3%), Vibrio fluvialis (3%), and rotavirus (3%). In total, 56 enteric infections were documented in 35 volunteers.
UR - http://www.scopus.com/inward/record.url?scp=0021963419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021963419&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(85)91388-1
DO - 10.1016/S0140-6736(85)91388-1
M3 - Article
C2 - 2857430
SN - 0140-6736
VL - 1
SP - 381
EP - 383
JO - The Lancet
JF - The Lancet
IS - 8425
ER -